William Taranto spoke about his near decade at Merck Global Health Innovation Fund and how corporate venturing has evolved in that time
Month: June 2019
UK performing well despite political turbulence
Innovative region: UK
61draw paints series B picture
The TAL Education-backed live-video art lesson provider has collected tens of millions of dollars in a series B round co-led by Qiming Venture Partners and Matrix Partners China.
Venturing increases in May
Monthly analysis: May 2019
Research reward – GUV’s award for spinout investment
Winner of the CVC Investment in a Spinout of the Year: Ribon Therapeutics – Novartis Venture Fund, Johnson & Johnson Innovation–JJDC, Takeda Ventures, Celgene
Optimism in climate change – disruption with social attitude
Editorial from the launch issue of GCV’s sister title, Global Impact Venturing
Fresh opportunities for corporate venturers
June issue editorial by James Mawson, editor in chief
Zhenkunhang procures $160m in series D funding
Tencent has led a $160m series D round for business-to-business e-commerce platform Zhenkunhang that was also backed by return investor Legend Capital.
Cathay catches $358m for corporate-backed fund
ADP, SEB, Michelin, Valeo, Accor, BioMérieux, Dassault, JCDecaux Holding, Kering and Pernod Ricard have all contributed to the venture fund’s $358m first close.
RootCloud digs up series B funding
The internet-of-things software provider has sourced $72.2m in a series B round that featured Galaxy Holding Group.
Collective Health cruises to $205m round
The enterprise health plan software provider has now raised more than $430m in total, with SoftBank Vision Fund leading a round that also featured GV.
Gobi takes Sunway to Malaysia fund
Sunway Group has joined Gobi Partners and Mavcap in Malaysia SuperSeed Fund II, which will invest at pre-series A stage.
Diagram Ventures draws up second fund
Power Corporation’s Portag3 Ventures unit has anchored the venture capital investor and incubator’s second vehicle, which will focus on financial and insurance technology.
Allscripts wraps up ZappRx acquisition
GlaxoSmithKline and Alphabet have exited the online drug delivery platform, which has been acquired by Allscripts in a deal reported to be less than $40m in size.